{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:11:01Z","timestamp":1790655061257,"version":"4.1.0"},"reference-count":168,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T00:00:00Z","timestamp":1537228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>The mineralocorticoid receptor (MR) was first identified as a blood pressure regulator, modulating renal sodium handling in response to its principal ligand aldosterone. The mineralocorticoid receptor is also expressed in many tissues other than the kidney, such as adipose tissue, heart and vasculature. Recent studies have shown that MR plays a relevant role in the control of cardiovascular and metabolic function, as well as in adipogenesis. Dysregulation of aldosterone\/MR signaling represents an important cause of disease as high plasma levels of aldosterone are associated with hypertension, obesity and increased cardiovascular risk. Aldosterone displays powerful vascular effects and acts as a potent pro-fibrotic agent in cardiovascular remodeling. Mineralocorticoid receptor activation regulates genes involved in vascular and cardiac fibrosis, calcification and inflammation. This review focuses on the role of novel potential biomarkers related to aldosterone\/MR system that could help identify cardiovascular and metabolic detrimental conditions, as a result of altered MR activation. Specifically, we discuss: (1) how MR signaling regulates the number and function of different subpopulations of circulating and intra-tissue immune cells; (2) the role of aldosterone\/MR system in mediating cardiometabolic diseases induced by obesity; and (3) the role of several MR downstream molecules as novel potential biomarkers of cardiometabolic diseases, end-organ damage and rehabilitation outcome.<\/jats:p>","DOI":"10.3390\/biom8030096","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T11:52:29Z","timestamp":1537271549000},"page":"96","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Mineralocorticoid Receptor and Aldosterone-Related Biomarkers of End-Organ Damage in Cardiometabolic Disease"],"prefix":"10.3390","volume":"8","author":[{"given":"Stefania","family":"Gorini","sequence":"first","affiliation":[{"name":"Laboratory of Cardiovascular Endocrinology, IRCCS San Raffaele Pisana, Via di Val Cannuta 247, 00166 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2943-7631","authenticated-orcid":false,"given":"Vincenzo","family":"Marzolla","sequence":"additional","affiliation":[{"name":"Laboratory of Cardiovascular Endocrinology, IRCCS San Raffaele Pisana, Via di Val Cannuta 247, 00166 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Mammi","sequence":"additional","affiliation":[{"name":"Laboratory of Cardiovascular Endocrinology, IRCCS San Raffaele Pisana, Via di Val Cannuta 247, 00166 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Armani","sequence":"additional","affiliation":[{"name":"Laboratory of Cardiovascular Endocrinology, IRCCS San Raffaele Pisana, Via di Val Cannuta 247, 00166 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Caprio","sequence":"additional","affiliation":[{"name":"Laboratory of Cardiovascular Endocrinology, IRCCS San Raffaele Pisana, Via di Val Cannuta 247, 00166 Rome, Italy"},{"name":"Department of Human Sciences and Promotion of the Quality of Life, San Raffaele Roma Open University, 00166 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,9,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1085\/jgp.20028638","article-title":"Hormonal regulation of the epithelial sodium channel ENaC: N or Po?","volume":"120","author":"Rossier","year":"2002","journal-title":"J. Gen. Physiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.coph.2013.11.010","article-title":"Epithelial sodium channel (ENaC) and the control of blood pressure","volume":"15","author":"Rossier","year":"2014","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.febslet.2013.05.013","article-title":"Genetic dissection of sodium and potassium transport along the aldosterone-sensitive distal nephron: Importance in the control of blood pressure and hypertension","volume":"587","author":"Rossier","year":"2013","journal-title":"FEBS Lett."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.3037703","article-title":"Cloning of human mineralocorticoid receptor complementary DNA: Structural and functional kinship with the glucocorticoid receptor","volume":"237","author":"Arriza","year":"1987","journal-title":"Science"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.steroids.2014.05.001","article-title":"Mineralocorticoid receptor in adipocytes and macrophages: A promising target to fight metabolic syndrome","volume":"91","author":"Marzolla","year":"2014","journal-title":"Steroids"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.RES.71.3.503","article-title":"Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor","volume":"71","author":"Lombes","year":"1992","journal-title":"Circ. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/01.CIR.92.2.175","article-title":"Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase in the human heart","volume":"92","author":"Lombes","year":"1995","journal-title":"Circulation"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1210\/endo.132.6.8504747","article-title":"Aldosterone stimulated differentiation of mouse 3T3-L1 cells into adipocytes","volume":"132","author":"Rondinone","year":"1993","journal-title":"Endocrinology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"T67","DOI":"10.1530\/JOE-17-0009","article-title":"30 years of the mineralocorticoid receptor: The role of the mineralocorticoid receptor in the vasculature","volume":"234","author":"DuPont","year":"2017","journal-title":"J. Endocrinol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/CIRCRESAHA.108.174235","article-title":"Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion","volume":"102","author":"Caprio","year":"2008","journal-title":"Circ. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JME-15-0122","article-title":"Cellular mechanisms of MR regulation of adipose tissue physiology and pathophysiology","volume":"55","author":"Armani","year":"2015","journal-title":"J. Mol. Endocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Funder, J.W. (2017). Aldosterone and mineralocorticoid receptors-physiology and pathophysiology. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18051032"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1210\/jc.2007-1088","article-title":"Body mass index predicts aldosterone production in normotensive adults on a high-salt diet","volume":"92","author":"Adler","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/j.1550-8528.1999.tb00418.x","article-title":"Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women","volume":"7","author":"Goodfriend","year":"1999","journal-title":"Obes. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1210\/jc.2003-030490","article-title":"50th anniversary of aldosterone","volume":"88","author":"Williams","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/01.RES.0000159937.05502.d1","article-title":"Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells","volume":"96","author":"Jaffe","year":"2005","journal-title":"Circ. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/01.ATV.0000258414.59393.89","article-title":"Mineralocorticoid receptor activation promotes vascular cell calcification","volume":"27","author":"Jaffe","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0895-7061(01)02291-9","article-title":"Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: Role of endothelin-1","volume":"15","author":"Park","year":"2002","journal-title":"Am. J. Hypertens."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.lfs.2017.05.002","article-title":"Vascular dysfunction and fibrosis in stroke-prone spontaneously hypertensive rats: The aldosterone-mineralocorticoid receptor-Nox1 axis","volume":"179","author":"Harvey","year":"2017","journal-title":"Life Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/j.2040-4603.2014.tb00569.x","article-title":"The multifaceted mineralocorticoid receptor","volume":"4","year":"2014","journal-title":"Compr. Physiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/nm.1879","article-title":"Modification of mineralocorticoid receptor function by Rac1 GTPase: Implication in proteinuric kidney disease","volume":"14","author":"Shibata","year":"2008","journal-title":"Nat. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nrneph.2012.282","article-title":"Role of Rac1-mineralocorticoid-receptor signalling in renal and cardiac disease","volume":"9","author":"Nagase","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/HYPERTENSIONAHA.115.06054","article-title":"Rac1-mediated activation of mineralocorticoid receptor in pressure overload-induced cardiac injury","volume":"67","author":"Ayuzawa","year":"2016","journal-title":"Hypertension"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.111.185520","article-title":"Oxidative stress causes mineralocorticoid receptor activation in rat cardiomyocytes: Role of small GTPase Rac1","volume":"59","author":"Nagase","year":"2012","journal-title":"Hypertension"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/ajh\/hpu224","article-title":"The expression of Rac1 and mineralocorticoid pathway-dependent genes are associated with different responses to salt intake","volume":"28","author":"Carvajal","year":"2015","journal-title":"Am. J. Hypertens."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"T107","DOI":"10.1530\/JOE-16-0659","article-title":"30 years of the mineralocorticoid receptor: Nongenomic effects via the mineralocorticoid receptor","volume":"234","author":"Ruhs","year":"2017","journal-title":"J. Endocrinol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jsbmb.2017.01.016","article-title":"Rapid actions of aldosterone revisited: Receptors in the limelight","volume":"176","author":"Wehling","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00424-007-0211-9","article-title":"Altered collagen homeostasis in human aortic smooth muscle cells (HAoSMCs) induced by aldosterone","volume":"454","author":"Gekle","year":"2007","journal-title":"Pflug. Arch."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1159\/000339500","article-title":"Aldosterone induces kidney fibroblast proliferation via activation of growth factor receptors and PI3K\/MAPK signalling","volume":"120","author":"Huang","year":"2012","journal-title":"Nephron Exp. Nephrol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1161\/HYPERTENSIONAHA.109.148783","article-title":"Elevated mineralocorticoid receptor activity in aged rat vascular smooth muscle cells promotes a proinflammatory phenotype via extracellular signal-regulated kinase 1\/2 mitogen-activated protein kinase and epidermal growth factor receptor-dependent pathways","volume":"55","author":"Krug","year":"2010","journal-title":"Hypertension"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.tem.2009.05.006","article-title":"Mineralocorticoid receptors in the metabolic syndrome","volume":"20","author":"Zennaro","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/CS20070123","article-title":"Aldosterone and end-organ damage","volume":"113","author":"Marney","year":"2007","journal-title":"Clin. Sci. (Lond.)"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/1440-1681.12145","article-title":"Aldosterone, organ damage and dietary salt","volume":"40","author":"Catena","year":"2013","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_34","first-page":"893","article-title":"Mineralocorticoid excess, dietary sodium, and myocardial fibrosis","volume":"120","author":"Brilla","year":"1992","journal-title":"J. Lab. Clin. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11906-004-0001-0","article-title":"Primary aldosteronism: A needle in a haystack or a yellow cab on fifth avenue?","volume":"6","author":"Rossi","year":"2004","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJM196511182732106","article-title":"Hypertension, the potassium ion and impaired carbohydrate tolerance","volume":"273","author":"Conn","year":"1965","journal-title":"N. Engl. J. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.HYP.0000253258.36141.c7","article-title":"Association of adrenal steroids with hypertension and the metabolic syndrome in blacks","volume":"49","author":"Kidambi","year":"2007","journal-title":"Hypertension"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1210\/jc.2005-1733","article-title":"Prevalence and characteristics of the metabolic syndrome in primary aldosteronism","volume":"91","author":"Fallo","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1210\/en.2013-1115","article-title":"Antioxidant N-acetylcysteine protects pancreatic \u03b2-cells against aldosterone-induced oxidative stress and apoptosis in female db\/db mice and insulin-producing MIN6 cells","volume":"154","author":"Jin","year":"2013","journal-title":"Endocrinology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.steroids.2014.08.016","article-title":"Effects of aldosterone on insulin sensitivity and secretion","volume":"91","author":"Luther","year":"2014","journal-title":"Steroids"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/HJH.0b013e3280108e6f","article-title":"Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: An observational study","volume":"25","author":"Giacchetti","year":"2007","journal-title":"J. Hypertens."},{"key":"ref_43","first-page":"21","article-title":"Insulin action in primary hyperaldosteronism before and after surgical or pharmacological treatment","volume":"108","author":"Sindelka","year":"2000","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.33549\/physiolres.930000.49.241","article-title":"Impaired insulin action in primary hyperaldosteronism","volume":"49","author":"Widimsky","year":"2000","journal-title":"Physiol. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1210\/jc.2006-0736","article-title":"Insulin sensitivity in patients with primary aldosteronism: A follow-up study","volume":"91","author":"Catena","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/CIRCULATIONAHA.107.708537","article-title":"Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: The framingham offspring study","volume":"116","author":"Ingelsson","year":"2007","journal-title":"Circulation"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/CIRCIMAGING.112.974576","article-title":"Demonstration of blood pressure-independent noninfarct myocardial fibrosis in primary aldosteronism: A cardiac magnetic resonance imaging study","volume":"5","author":"Freel","year":"2012","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1530\/JOE-14-0597","article-title":"An update on novel mechanisms of primary aldosteronism","volume":"224","author":"Zennaro","year":"2015","journal-title":"J. Endocrinol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.CIR.95.6.1471","article-title":"Remodeling of the left ventricle in primary aldosteronism due to conn\u2019s adenoma","volume":"95","author":"Rossi","year":"1997","journal-title":"Circulation"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ahj.2011.06.015","article-title":"Measuring and targeting aldosterone and renin in atherosclerosis\u2014A review of clinical data","volume":"162","author":"Hillaert","year":"2011","journal-title":"Am. Heart J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1093\/eurheartj\/ehr266","article-title":"Aldosterone promotes atrial fibrillation","volume":"33","author":"Reil","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0008-6363(97)00091-6","article-title":"Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients","volume":"35","author":"MacFadyen","year":"1997","journal-title":"Cardiovasc. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"H813","DOI":"10.1152\/ajpheart.00113.2003","article-title":"Aldosteronism: An immunostimulatory state precedes proinflammatory\/fibrogenic cardiac phenotype","volume":"285","author":"Gerling","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","article-title":"Aldosterone-induced inflammation in the rat heart: Role of oxidative stress","volume":"161","author":"Sun","year":"2002","journal-title":"Am. J. Pathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1084\/jem.20070657","article-title":"Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction","volume":"204","author":"Guzik","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/CIRCRESAHA.110.217299","article-title":"Central and peripheral mechanisms of t-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension","volume":"107","author":"Marvar","year":"2010","journal-title":"Circ. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1172\/JCI41080","article-title":"Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice","volume":"120","author":"Usher","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0002-8703(49)91003-0","article-title":"Influence of sodium chloride upon the actions of desoxycorticosteron acetate","volume":"37","author":"Selye","year":"1949","journal-title":"Am. Heart J."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/HYPERTENSIONAHA.107.098012","article-title":"Mineralocorticoid receptor activation and oxidative stress","volume":"50","author":"Funder","year":"2007","journal-title":"Hypertension"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/HYPERTENSIONAHA.107.095489","article-title":"Aldosterone and vascular inflammation","volume":"51","author":"Brown","year":"2008","journal-title":"Hypertension"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1182\/blood-2005-04-1723","article-title":"Ligand-specific glucocorticoid receptor activation in human platelets","volume":"106","author":"Moraes","year":"2005","journal-title":"Blood"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/HYPERTENSIONAHA.115.06530","article-title":"Deoxycorticosterone acetate\/salt-induced cardiac but not renal injury is mediated by endothelial mineralocorticoid receptors independently from blood pressure","volume":"67","author":"Lother","year":"2016","journal-title":"Hypertension"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijcard.2017.01.013","article-title":"Essential role of ICAM-1 in aldosterone-induced atherosclerosis","volume":"232","author":"Marzolla","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.2174\/138161208786898743","article-title":"The mineralocorticoid receptor in endothelial physiology and disease: Novel concepts in the understanding of erectile dysfunction","volume":"14","author":"Caprio","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.mce.2011.09.008","article-title":"Mechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosis","volume":"350","author":"Young","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1161\/HYPERTENSIONAHA.113.01803","article-title":"Endothelial cell mineralocorticoid receptors regulate deoxycorticosterone\/salt-mediated cardiac remodeling and vascular reactivity but not blood pressure","volume":"63","author":"Rickard","year":"2014","journal-title":"Hypertension"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3389\/fphar.2017.00313","article-title":"Mineralocorticoid receptor signaling as a therapeutic target for renal and cardiac fibrosis","volume":"8","author":"Tesch","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1096\/fj.15-271734","article-title":"Excess aldosterone is a critical danger signal for inflammasome activation in the development of renal fibrosis in mice","volume":"29","author":"Kadoya","year":"2015","journal-title":"FASEB J."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"F556","DOI":"10.1152\/ajprenal.00332.2016","article-title":"NLRP3 inflammasome activation contributes to aldosterone-induced podocyte injury","volume":"312","author":"Bai","year":"2017","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1530\/JOE-17-0351","article-title":"Eplerenone prevented obesity-induced inflammasome activation and glucose intolerance","volume":"235","author":"Wada","year":"2017","journal-title":"J. Endocrinol."},{"key":"ref_73","first-page":"523","article-title":"Evidence for an initial, thymus independent and a chronic, thymus dependent phase of doca and salt hypertension in mice","volume":"84","author":"Svendsen","year":"1976","journal-title":"Acta Pathol. Microbiol. Scand. A"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/eji.201344265","article-title":"Mineralocorticoid receptor signaling reduces numbers of circulating human na\u00efve T cells and increases their CD62L, CCR7, and CXCR4 expression","volume":"44","author":"Besedovsky","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.109.145094","article-title":"Interleukin 17 Promotes Angiotensin II-Induced Hypertension and Vascular Dysfunction","volume":"55","author":"Madhur","year":"2010","journal-title":"Hypertension"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/HYPERTENSIONAHA.113.00689","article-title":"Immunosenescent CD8+ T Cells and C-X-C Chemokine Receptor Type 3 Chemokines are Increased in Human Hypertension","volume":"62","author":"Youn","year":"2013","journal-title":"Hypertension"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/HYPERTENSIONAHA.113.02883","article-title":"Spironolactone decreases doca-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes","volume":"63","author":"Amador","year":"2014","journal-title":"Hypertension"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/HYPERTENSIONAHA.117.09070","article-title":"Mineralocorticoid receptor deficiency in T cells attenuates pressure overload-induced cardiac hypertrophy and dysfunction through modulating T-cell activation","volume":"70","author":"Li","year":"2017","journal-title":"Hypertension"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4049\/jimmunol.0802886","article-title":"Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity","volume":"184","author":"Herrada","year":"2010","journal-title":"J. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0092-8674(01)00449-4","article-title":"Dendritic cells: Specialized and regulated antigen processing machines","volume":"106","author":"Mellman","year":"2001","journal-title":"Cell"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory t cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"11695","DOI":"10.1073\/pnas.0601347103","article-title":"Regulation of T cell activation and tolerance by PDL2","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"7757","DOI":"10.4049\/jimmunol.180.11.7757","article-title":"Presence of suppressor HIV-specific CD8+ T cells is associated with increased PD-1 expression on effector CD8+ T cells","volume":"180","author":"Elrefaei","year":"2008","journal-title":"J. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Jo, J., Gavrilova, O., Pack, S., Jou, W., Mullen, S., Sumner, A.E., Cushman, S.W., and Periwal, V. (2009). Hypertrophy and\/or hyperplasia: Dynamics of adipose tissue growth. PLoS Comput. Biol., 5.","DOI":"10.1371\/journal.pcbi.1000324"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1073\/pnas.1133870100","article-title":"Monocyte chemoattractant protein 1 in obesity and insulin resistance","volume":"100","author":"Sartipy","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_86","first-page":"1267","article-title":"Regulation of interleukin 8 production and gene expression in human adipose tissue in vitro","volume":"86","author":"Bruun","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"461S","DOI":"10.1093\/ajcn\/83.2.461S","article-title":"Obesity and the role of adipose tissue in inflammation and metabolism","volume":"83","author":"Greenberg","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.diabres.2014.04.006","article-title":"Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes","volume":"105","author":"Esser","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"E1035","DOI":"10.1152\/ajpendo.00029.2013","article-title":"Regulation of 11\u03b2-HSD1 expression during adipose tissue expansion by hypoxia through different activities of NF-\u03baB and HIF-1\u03b1","volume":"304","author":"Lee","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1172\/JCI29881","article-title":"Obesity induces a phenotypic switch in adipose tissue macrophage polarization","volume":"117","author":"Lumeng","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1677\/JOE-09-0292","article-title":"The balance between gluco- and mineralo-corticoid action critically determines inflammatory adipocyte responses","volume":"204","author":"Hoppmann","year":"2010","journal-title":"J. Endocrinol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/cvr\/cvp191","article-title":"Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice","volume":"84","author":"Hirata","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1734-1140(13)70983-6","article-title":"Eplerenone promotes alternative activation in human monocyte-derived macrophages","volume":"65","author":"Labuzek","year":"2013","journal-title":"Pharmacol. Rep."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1096\/fj.13-245415","article-title":"Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high-fat-diet-fed mice","volume":"28","author":"Armani","year":"2014","journal-title":"FASEB J."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.748640","article-title":"Mineralocorticoid Receptor Blockade Reverses Obesity-Related Changes in Expression of Adiponectin, Peroxisome Proliferator-Activated Receptor-gamma, and Proinflammatory Adipokines","volume":"117","author":"Guo","year":"2008","journal-title":"Circulation"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1096\/fj.06-7970com","article-title":"Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis","volume":"21","author":"Caprio","year":"2007","journal-title":"FASEB J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1101\/gad.948702","article-title":"C\/EBPalpha induces adipogenesis through PPARgamma: A unified pathway","volume":"16","author":"Rosen","year":"2002","journal-title":"Genes Dev."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1210\/en.2010-0674","article-title":"Antiadipogenic effects of the mineralocorticoid receptor antagonist drospirenone: Potential implications for the treatment of metabolic syndrome","volume":"152","author":"Caprio","year":"2011","journal-title":"Endocrinology"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1210\/jc.2010-0097","article-title":"Analysis of insulin sensitivity in adipose tissue of patients with primary aldosteronism","volume":"95","author":"Urbanet","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/ijo.2014.68","article-title":"Mineralocorticoid vs glucocorticoid receptors: Solo players or team mates in the control of adipogenesis?","volume":"38","author":"Armani","year":"2014","journal-title":"Int. J. Obes. (Lond.)"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/HYPERTENSIONAHA.114.04981","article-title":"Adipocyte mineralocorticoid receptor activation leads to metabolic syndrome and induction of prostaglandin D2 synthase","volume":"66","author":"Urbanet","year":"2015","journal-title":"Hypertension"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jacc.2008.12.068","article-title":"Obesity and cardiovascular disease: Risk factor, paradox, and impact of weight loss","volume":"53","author":"Lavie","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1161\/01.HYP.0000231338.41548.fc","article-title":"Plasma aldosterone is independently associated with the metabolic syndrome","volume":"48","author":"Bochud","year":"2006","journal-title":"Hypertension"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/MED.0b013e3283533955","article-title":"Role of mineralocorticoid receptor in insulin resistance","volume":"19","author":"Garg","year":"2012","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s11906-010-0126-2","article-title":"Mineralocorticoid receptor antagonists and the metabolic syndrome","volume":"12","author":"Tirosh","year":"2010","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4070\/kcj.2017.0200","article-title":"Independent association of serum aldosterone level with metabolic syndrome and insulin resistance in korean adults","volume":"48","author":"Min","year":"2018","journal-title":"Korean Circ. J."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0899-9007(00)00422-6","article-title":"Obesity and cortisol","volume":"16","author":"Bjorntorp","year":"2000","journal-title":"Nutrition"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/ajh\/hpw003","article-title":"The role of aldosterone in obesity-related hypertension","volume":"29","author":"Kawarazaki","year":"2016","journal-title":"Am. J. Hypertens."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ccl.2010.04.001","article-title":"The role of aldosteronism in causing obesity-related cardiovascular risk","volume":"28","author":"Calhoun","year":"2010","journal-title":"Cardiol. Clin."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/cphy.c160037","article-title":"Impact of adrenal steroids on regulation of adipose tissue","volume":"7","author":"Infante","year":"2017","journal-title":"Compr. Physiol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"14211","DOI":"10.1073\/pnas.2336140100","article-title":"Human adipocytes secrete mineralocorticoid-releasing factors","volume":"100","author":"Schraven","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.mce.2011.09.011","article-title":"The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism","volume":"350","author":"Marzolla","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1161\/CIRCULATIONAHA.115.018226","article-title":"Adipocyte-derived hormone leptin is a direct regulator of aldosterone secretion, which promotes endothelial dysfunction and cardiac fibrosis","volume":"132","author":"Huby","year":"2015","journal-title":"Circulation"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.hfc.2013.12.004","article-title":"Arterial hypertension in patients with heart failure","volume":"10","author":"Diez","year":"2014","journal-title":"Heart Fail. Clin."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrm3904","article-title":"Remodelling the extracellular matrix in development and disease","volume":"15","author":"Bonnans","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00441-016-2431-9","article-title":"Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration","volume":"365","author":"Talman","year":"2016","journal-title":"Cell Tissue Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/eurheartj\/ehs375","article-title":"Matricellular proteins and matrix metalloproteinases mark the inflammatory and fibrotic response in human cardiac allograft rejection","volume":"34","author":"Vanhoutte","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/hr.2010.159","article-title":"From aldosteronism to oxidative stress: The role of excessive intracellular calcium accumulation","volume":"33","author":"Zia","year":"2010","journal-title":"Hypertens. Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.CIR.0000121426.43044.2B","article-title":"Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy","volume":"109","author":"Tsybouleva","year":"2004","journal-title":"Circulation"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1210\/endo-108-4-1216","article-title":"Plasma aldosterone and corticosterone responses to adrenocorticotropin, angiotensin, potassium, and stress in spontaneously hypertensive rats","volume":"108","author":"Sowers","year":"1981","journal-title":"Endocrinology"},{"key":"ref_121","first-page":"69","article-title":"Approach to the surgical management of primary aldosteronism","volume":"4","author":"Iacobone","year":"2015","journal-title":"Gland Surg."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/HYPERTENSIONAHA.111.187872","article-title":"Neutrophil gelatinase-associated lipocalin is a novel mineralocorticoid target in the cardiovascular system","volume":"59","author":"Latouche","year":"2012","journal-title":"Hypertension"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1681\/ASN.2006080882","article-title":"Dual action of neutrophil gelatinase-associated lipocalin","volume":"18","author":"Mori","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.advms.2015.01.001","article-title":"High expression of neutrophil gelatinase-associated lipocalin (NGAL) in the kidney proximal tubules of diabetic rats","volume":"60","author":"Liu","year":"2015","journal-title":"Adv. Med. Sci."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/jne.12000","article-title":"Immune-induced expression of lipocalin-2 in brain endothelial cells: Relationship with interleukin-6, cyclooxygenase-2 and the febrile response","volume":"25","author":"Hamzic","year":"2013","journal-title":"J. Neuroendocrinol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ejvs.2016.01.009","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) is associated with symptomatic carotid atherosclerosis and drives pro-inflammatory state in vitro","volume":"51","author":"Eilenberg","year":"2016","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.1016\/S0021-9258(18)82217-7","article-title":"Isolation and primary structure of ngal, a novel protein associated with human neutrophil gelatinase","volume":"268","author":"Kjeldsen","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03104","article-title":"Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron","volume":"432","author":"Flo","year":"2004","journal-title":"Nature"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Floderer, M., Prchal-Murphy, M., and Vizzardelli, C. (2014). Dendritic cell-secreted lipocalin2 induces CD8+ T-cell apoptosis, contributes to t-cell priming and leads to a TH1 phenotype. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0101881"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2217\/bmm.10.12","article-title":"Neutrophil gelatinase-associated lipocalin: A promising biomarker for human acute kidney injury","volume":"4","author":"Devarajan","year":"2010","journal-title":"Biomark. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/CIRCHEARTFAILURE.113.000242","article-title":"Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure","volume":"7","author":"Damman","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1161\/ATVBAHA.114.303718","article-title":"Elevated circulating lipocalin-2 levels independently predict incident cardiovascular events in men in a population-based cohort","volume":"34","author":"Wu","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1161\/HYPERTENSIONAHA.115.05431","article-title":"Neutrophil gelatinase-associated lipocalin, a novel mineralocorticoid biotarget, mediates vascular profibrotic effects of mineralocorticoids","volume":"66","author":"Tarjus","year":"2015","journal-title":"Hypertension"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1161\/HYPERTENSIONAHA.117.09791","article-title":"Aldosterone target NGAL (neutrophil gelatinase-associated lipocalin) is involved in cardiac remodeling after myocardial infarction through NF\u03ba\u03b2 pathway","volume":"70","author":"Buonafine","year":"2017","journal-title":"Hypertension"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Han, M., Li, Y., Liu, M., Li, Y., and Cong, B. (2012). Renal neutrophil gelatinase associated lipocalin expression in lipopolysaccharide-induced acute kidney injury in the rat. BMC Nephrol., 13.","DOI":"10.1186\/1471-2369-13-25"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/art.37840","article-title":"Differential role of lipocalin 2 during immune complex-mediated acute and chronic inflammation in mice","volume":"65","author":"Shashidharamurthy","year":"2013","journal-title":"Arthritis Rheum."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.yjmcc.2017.12.011","article-title":"Neutrophil gelatinase-associated lipocalin from immune cells is mandatory for aldosterone-induced cardiac remodeling and inflammation","volume":"115","author":"Buonafine","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1161\/HYPERTENSIONAHA.111.190512","article-title":"Aldosterone inhibits antifibrotic factors in mouse hypertensive heart","volume":"59","author":"Azibani","year":"2012","journal-title":"Hypertension"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/HJH.0000000000000149","article-title":"Leptin induces cardiac fibrosis through galectin-3, mtor and oxidative stress: Potential role in obesity","volume":"32","author":"Bartolome","year":"2014","journal-title":"J. Hypertens."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2353\/ajpath.2008.070938","article-title":"The galectin profile of the endothelium: Altered expression and localization in activated and tumor endothelial cells","volume":"172","author":"Thijssen","year":"2008","journal-title":"Am. J. Pathol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/ATVBAHA.107.159160","article-title":"Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction","volume":"28","author":"Papaspyridonos","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/ATVBAHA.112.300569","article-title":"Galectin-3 mediates aldosterone-induced vascular fibrosis","volume":"33","author":"Calvier","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jchf.2014.08.002","article-title":"The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries","volume":"3","author":"Calvier","year":"2015","journal-title":"JACC Heart Fail."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.carres.2008.08.038","article-title":"Modified citrus pectin anti-metastatic properties: One bullet, multiple targets","volume":"344","author":"Glinsky","year":"2009","journal-title":"Carbohydr. Res."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/HYPERTENSIONAHA.115.05876","article-title":"Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension","volume":"66","author":"Calvier","year":"2015","journal-title":"Hypertension"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/eurjhf\/hfr151","article-title":"Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: Insights from the CARE-HF (cardiac resynchronization in heart failure) trial","volume":"14","author":"Rossignol","year":"2012","journal-title":"Eur. J. Heart Fail."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1161\/ATVBAHA.114.304964","article-title":"Galectin-3 predicts long-term cardiovascular death in high-risk patients with coronary artery disease","volume":"35","author":"Maiolino","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/HYPERTENSIONAHA.115.06032","article-title":"Galectin-3 participates in cardiovascular remodeling associated with obesity","volume":"66","author":"Rousseau","year":"2015","journal-title":"Hypertension"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bbrc.2012.01.139","article-title":"Contribution of glucocorticoid-mineralocorticoid receptor pathway on the obesity-related adipocyte dysfunction","volume":"419","author":"Hirata","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1210\/en.2009-0869","article-title":"Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet","volume":"151","author":"Wada","year":"2010","journal-title":"Endocrinology"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/ijo.2016.19","article-title":"Galectin-3 inhibition prevents adipose tissue remodelling in obesity","volume":"40","author":"Calvier","year":"2016","journal-title":"Int. J. Obes. (Lond.)"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.biocel.2011.09.006","article-title":"Epicardial fat: From the biomolecular aspects to the clinical practice","volume":"43","author":"Iacobellis","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2174\/157340210791170994","article-title":"Leptin-induced sympathetic nerve activation: Signaling mechanisms and cardiovascular consequences in obesity","volume":"6","author":"Rahmouni","year":"2010","journal-title":"Curr. Hypertens. Rev."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2337\/diabetes.54.7.2012","article-title":"Role of selective leptin resistance in diet-induced obesity hypertension","volume":"54","author":"Rahmouni","year":"2005","journal-title":"Diabetes"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tcm.2008.10.001","article-title":"Implications of myocardial matrix remodeling by adipokines in obesity-related heart failure","volume":"18","author":"Schram","year":"2008","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.cellbi.2006.11.036","article-title":"Expression and immunohistochemical localization of galectin-3 in various mouse tissues","volume":"31","author":"Kim","year":"2007","journal-title":"Cell Biol. Int."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2796.2011.02476.x","article-title":"The fibrosis marker galectin-3 and outcome in the general population","volume":"272","author":"Gansevoort","year":"2012","journal-title":"J. Intern. Med."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1210\/jc.2009-1619","article-title":"Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetes","volume":"95","author":"Weigert","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Lin, Y.H., Chou, C.H., Wu, X.M., Chang, Y.Y., Hung, C.S., Chen, Y.H., Tzeng, Y.L., Wu, V.C., Ho, Y.L., and Hsieh, F.J. (2014). Aldosterone induced galectin-3 secretion in vitro and in vivo: From cells to humans. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0095254"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0090-6980(02)00134-X","article-title":"Prostaglandin D2 synthase enzymes and PPAR\u03b3 are co-expressed in mouse 3T3-L1 adipocytes and human tissues","volume":"70","author":"Jowsey","year":"2003","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"29946","DOI":"10.1074\/jbc.M502927200","article-title":"Accelerated Glucose Intolerance, Nephropathy, and Atherosclerosis in Prostaglandin D2 Synthase Knock-out Mice","volume":"280","author":"Ragolia","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.prostaglandins.2008.06.001","article-title":"Lipocalin-type prostaglandin D2 synthase stimulates glucose transport via enhanced GLUT4 translocation","volume":"87","author":"Ragolia","year":"2008","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbrc.2011.06.126","article-title":"Sustained expression of lipocalin-type prostaglandin D synthase in the antisense direction positively regulates adipogenesis in cloned cultured preadipocytes","volume":"411","author":"Chowdhury","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Virtue, S., Masoodi, M., Velagapudi, V., Tan, C.Y., Dale, M., Suorti, T., Slawik, M., Blount, M., Burling, K., and Campbell, M. (2012). Lipocalin prostaglandin D synthase and PPAR\u03b32 coordinate to regulate carbohydrate and lipid metabolism in vivo. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0039512"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cca.2014.10.031","article-title":"Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: How useful, how feasible?","volume":"443","author":"Emdin","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2015.01.015","article-title":"Biomarkers in heart failure","volume":"443","author":"Gruson","year":"2015","journal-title":"Clin. Chim. Acta"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/8\/3\/96\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:21:08Z","timestamp":1760196068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/8\/3\/96"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,18]]},"references-count":168,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,9]]}},"alternative-id":["biom8030096"],"URL":"https:\/\/doi.org\/10.3390\/biom8030096","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,18]]}}}